vs
Side-by-side financial comparison of CLARIVATE PLC (CLVT) and Hims & Hers Health, Inc. (HIMS). Click either name above to swap in a different company.
Hims & Hers Health, Inc. is the larger business by last-quarter revenue ($617.8M vs $585.5M, roughly 1.1× CLARIVATE PLC). Hims & Hers Health, Inc. runs the higher net margin — 3.3% vs -6.9%, a 10.2% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs -1.4%). CLARIVATE PLC produced more free cash flow last quarter ($78.9M vs $-2.5M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs -5.1%).
Clarivate Plc is a British-American publicly traded analytics company that operates a collection of subscription-based services, in the areas of bibliometrics and scientometrics; business and market intelligence, and competitive profiling for pharmacy and biotech, patents, and regulatory compliance; trademark protection, and domain and brand protection. Clarivate calculates the impact factor of scientific journals, using data from its Web of Science product family, that also includes services...
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
CLVT vs HIMS — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $585.5M | $617.8M |
| Net Profit | $-40.2M | $20.6M |
| Gross Margin | 67.2% | 71.9% |
| Operating Margin | 5.2% | 1.5% |
| Net Margin | -6.9% | 3.3% |
| Revenue YoY | -1.4% | 28.4% |
| Net Profit YoY | 61.3% | -20.8% |
| EPS (diluted) | $-0.06 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $585.5M | — | ||
| Q4 25 | $617.0M | $617.8M | ||
| Q3 25 | $623.1M | $599.0M | ||
| Q2 25 | $621.4M | $544.8M | ||
| Q1 25 | $593.7M | $586.0M | ||
| Q4 24 | $663.0M | $481.1M | ||
| Q3 24 | $622.2M | $401.6M | ||
| Q2 24 | $650.3M | $315.6M |
| Q1 26 | $-40.2M | — | ||
| Q4 25 | $3.1M | $20.6M | ||
| Q3 25 | $-28.3M | $15.8M | ||
| Q2 25 | $-72.0M | $42.5M | ||
| Q1 25 | $-103.9M | $49.5M | ||
| Q4 24 | $-191.8M | $26.0M | ||
| Q3 24 | $-65.6M | $75.6M | ||
| Q2 24 | $-304.3M | $13.3M |
| Q1 26 | 67.2% | — | ||
| Q4 25 | 66.8% | 71.9% | ||
| Q3 25 | 65.0% | 73.8% | ||
| Q2 25 | 67.2% | 76.4% | ||
| Q1 25 | 65.1% | 73.5% | ||
| Q4 24 | 65.7% | 76.8% | ||
| Q3 24 | 66.2% | 79.2% | ||
| Q2 24 | 67.2% | 81.3% |
| Q1 26 | 5.2% | — | ||
| Q4 25 | 6.7% | 1.5% | ||
| Q3 25 | 7.1% | 2.0% | ||
| Q2 25 | 1.1% | 4.9% | ||
| Q1 25 | -3.5% | 9.9% | ||
| Q4 24 | -9.4% | 3.9% | ||
| Q3 24 | 3.5% | 5.6% | ||
| Q2 24 | -36.9% | 3.5% |
| Q1 26 | -6.9% | — | ||
| Q4 25 | 0.5% | 3.3% | ||
| Q3 25 | -4.5% | 2.6% | ||
| Q2 25 | -11.6% | 7.8% | ||
| Q1 25 | -17.5% | 8.4% | ||
| Q4 24 | -28.9% | 5.4% | ||
| Q3 24 | -10.5% | 18.8% | ||
| Q2 24 | -46.8% | 4.2% |
| Q1 26 | $-0.06 | — | ||
| Q4 25 | $0.00 | $0.08 | ||
| Q3 25 | $-0.04 | $0.06 | ||
| Q2 25 | $-0.11 | $0.17 | ||
| Q1 25 | $-0.15 | $0.20 | ||
| Q4 24 | $-0.27 | $0.10 | ||
| Q3 24 | $-0.09 | $0.32 | ||
| Q2 24 | $-0.46 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $228.6M |
| Total DebtLower is stronger | $4.3B | — |
| Stockholders' EquityBook value | $4.8B | $540.9M |
| Total Assets | $10.9B | $2.2B |
| Debt / EquityLower = less leverage | 0.89× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $329.2M | $228.6M | ||
| Q3 25 | $318.7M | $345.8M | ||
| Q2 25 | $362.6M | $1.1B | ||
| Q1 25 | $354.0M | $273.7M | ||
| Q4 24 | $295.2M | $220.6M | ||
| Q3 24 | $388.5M | $165.5M | ||
| Q2 24 | $376.4M | $129.3M |
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.3B | — | ||
| Q3 25 | $4.4B | — | ||
| Q2 25 | $4.5B | — | ||
| Q1 25 | $4.5B | — | ||
| Q4 24 | $4.5B | — | ||
| Q3 24 | $4.6B | — | ||
| Q2 24 | $4.6B | — |
| Q1 26 | $4.8B | — | ||
| Q4 25 | $4.8B | $540.9M | ||
| Q3 25 | $4.9B | $581.0M | ||
| Q2 25 | $5.0B | $562.7M | ||
| Q1 25 | $5.0B | $549.3M | ||
| Q4 24 | $5.1B | $476.7M | ||
| Q3 24 | $5.5B | $440.1M | ||
| Q2 24 | $5.6B | $362.0M |
| Q1 26 | $10.9B | — | ||
| Q4 25 | $11.1B | $2.2B | ||
| Q3 25 | $11.2B | $2.2B | ||
| Q2 25 | $11.4B | $1.9B | ||
| Q1 25 | $11.5B | $891.7M | ||
| Q4 24 | $11.5B | $707.5M | ||
| Q3 24 | $12.0B | $602.3M | ||
| Q2 24 | $12.1B | $480.5M |
| Q1 26 | 0.89× | — | ||
| Q4 25 | 0.89× | — | ||
| Q3 25 | 0.90× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.90× | — | ||
| Q4 24 | 0.88× | — | ||
| Q3 24 | 0.84× | — | ||
| Q2 24 | 0.83× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $134.7M | $61.3M |
| Free Cash FlowOCF − Capex | $78.9M | $-2.5M |
| FCF MarginFCF / Revenue | 13.5% | -0.4% |
| Capex IntensityCapex / Revenue | 9.5% | 10.3% |
| Cash ConversionOCF / Net Profit | — | 2.98× |
| TTM Free Cash FlowTrailing 4 quarters | $333.9M | $57.4M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $134.7M | — | ||
| Q4 25 | $159.9M | $61.3M | ||
| Q3 25 | $181.1M | $148.7M | ||
| Q2 25 | $116.3M | $-19.1M | ||
| Q1 25 | $171.2M | $109.1M | ||
| Q4 24 | $141.3M | $86.4M | ||
| Q3 24 | $202.9M | $85.3M | ||
| Q2 24 | $126.2M | $53.6M |
| Q1 26 | $78.9M | — | ||
| Q4 25 | $89.2M | $-2.5M | ||
| Q3 25 | $115.5M | $79.3M | ||
| Q2 25 | $50.3M | $-69.5M | ||
| Q1 25 | $110.3M | $50.1M | ||
| Q4 24 | $59.1M | $59.5M | ||
| Q3 24 | $126.3M | $79.4M | ||
| Q2 24 | $60.3M | $47.6M |
| Q1 26 | 13.5% | — | ||
| Q4 25 | 14.5% | -0.4% | ||
| Q3 25 | 18.5% | 13.2% | ||
| Q2 25 | 8.1% | -12.8% | ||
| Q1 25 | 18.6% | 8.5% | ||
| Q4 24 | 8.9% | 12.4% | ||
| Q3 24 | 20.3% | 19.8% | ||
| Q2 24 | 9.3% | 15.1% |
| Q1 26 | 9.5% | — | ||
| Q4 25 | 11.5% | 10.3% | ||
| Q3 25 | 10.5% | 11.6% | ||
| Q2 25 | 10.6% | 9.3% | ||
| Q1 25 | 10.3% | 10.1% | ||
| Q4 24 | 12.4% | 5.6% | ||
| Q3 24 | 12.3% | 1.5% | ||
| Q2 24 | 10.1% | 1.9% |
| Q1 26 | — | — | ||
| Q4 25 | 51.58× | 2.98× | ||
| Q3 25 | — | 9.43× | ||
| Q2 25 | — | -0.45× | ||
| Q1 25 | — | 2.20× | ||
| Q4 24 | — | 3.32× | ||
| Q3 24 | — | 1.13× | ||
| Q2 24 | — | 4.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLVT
| Subscription | $397.5M | 68% |
| Re-occurring | $108.6M | 19% |
| Transactional | $79.4M | 14% |
HIMS
Segment breakdown not available.
